RVMD
The table below shows Revolution Medicines, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $440.94M | $217.44M | $402.44M | $333.55M | $201.26M | $275.71M |
| Short-term investments | $1.47B | $1.71B | $1.73B | $1.77B | $1.35B | $1.32B |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.97B |
| $1.98B |
| $2.18B |
| $2.13B |
| $1.58B |
| $1.62B |
| Property, plant & equipment | $31.48M | $32.93M | $33.05M | $27.15M | $24.81M | $25.28M |
| Goodwill | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M |
| Total assets | $2.25B | $2.25B | $2.43B | $2.37B | $1.76B | $1.81B |
| Accounts payable | $80.54M | $74.85M | $56.76M | $47.51M | $24.46M | $29.32M |
| Total current liabilities | $289.60M | $245.62M | $184.53M | $158.60M | $110.86M | $105.33M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $753.82M | $655.02M | $564.20M | $287.20M | $196.69M | $189.59M |
| Retained earnings | -$3.32B | -$2.50B | -$2.20B | -$1.95B | -$1.54B | -$1.39B |
| Total equity | $1.50B | $1.60B | $1.87B | $2.08B | $1.57B | $1.62B |